SCHEMBL3916029

SCHEMBL3916029

N=C1NC(=O)C(CC(=O)Nc2ccc(Cl)c(Cl)c2)S1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
MAP2K1 Q02750 1/20 0.60
MAPT P10636 10/20 0.58
MEN1 O00255 6/20 0.56
KMT2A Q03164 6/20 0.56
PLA2G1B P04054 1/20 0.56
ATG4B Q9Y4P1 1/20 0.56
TDP1 Q9NUW8 2/20 0.56
HTT P42858 1/20 0.56
SAE1 Q9UBE0 1/20 0.56
UBA2 Q9UBT2 1/20 0.56
POLB P06746 1/20 0.53
XBP1 P17861 1/20 0.53
TP53 P04637 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPC1 O15118 1/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 1/20 0.51
ABL1 P00519 1/20 0.51
RECQL P46063 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3924129 0.91 ABL1 (0.63) LMNAMAP2K1MAPTMEN1KMT2A
SCHEMBL3915867 0.84 TDP1 (0.60) MAPTMEN1KMT2ATDP1HTT
SCHEMBL3913170 0.84 MAPT (0.56) LMNAMAP2K1MAPTMEN1KMT2A
SCHEMBL19828191 0.82 MAPT (0.60) LMNAMAP2K1MAPTMEN1KMT2A
SCHEMBL3913448 0.81 MAPT (0.58) LMNAMAP2K1MAPTMEN1KMT2A
SCHEMBL3914469 0.81 MAPT (0.55) MAPTMEN1KMT2AHTTPOLB
SCHEMBL3913891 0.80 MAPT (0.52) MAPTMEN1KMT2ATDP1POLB
SCHEMBL22639695 0.80 KMT2A (0.63) MAPTMEN1KMT2ATDP1POLB
SCHEMBL3914048 0.80 MAPT (0.52) MAPTMEN1KMT2ATDP1POLB
SCHEMBL3922116 0.80 KMT2A (0.52) MAPTMEN1KMT2ATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270720-A1 Iminothiazolidinone derivatives as SFRP-1 antagonists WYETH (US) 2006-11-30 US claimed
US-7563813-B2 Iminothiazolidinone derivatives as SFRP-1 antagonists WYETH (US) 2009-07-21 US disclosed
US-20060270720-A1 Iminothiazolidinone derivatives as SFRP-1 antagonists WYETH (US) 2006-11-30 US disclosed
WO-2006124887-A1 IMINOTHIAZOLIDINONE DERIVATIVES AS SFRP-1 ANTAGONISTS WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270720-A1 Iminothiazolidinone derivatives as SFRP-1 antagonists SFRP1, FZD7, DKK1 LMNA 4353/4885MAP2K1 3535/4885MAPT 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.